Please fill out the brief form below. If you would like to receive Mtech news and event updates via email.
The Biopharmaceutical Advancement Facility (BAF), founded in 2010, specializes in the development of cell culture-based biopharmaceutical products. Specific services offered include: antibody and protein production, cell bank production and short term storage, bioreactor process development, scale-up and scale-down studies, and cell clarification.
Facility staff offers extensive experience with a range of cell lines: HEK293, CHO, Sf9, NSO, MSCs, and many other primary cell lines. In the short time since its inception, BAF has supported over 25 cell culture, stem cell, and recombinant biotherapeutic production projects. The facility has also been integral in the prototype testing of several biomanufacturing technologies.
The facility is not restricted by current good manufacturing practices (cGMPs); however, production processes are directly transferable to partners operating under cGMPs.